• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma.

作者信息

Gallamini Andrea

出版信息

Haematologica. 2010 Jul;95(7):1046-8. doi: 10.3324/haematol.2010.024885.

DOI:10.3324/haematol.2010.024885
PMID:20595100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2895025/
Abstract
摘要

相似文献

1
Positron emission tomography scanning: a new paradigm for the management of Hodgkin's lymphoma.正电子发射断层扫描：霍奇金淋巴瘤管理的新范式
Haematologica. 2010 Jul;95(7):1046-8. doi: 10.3324/haematol.2010.024885.
2
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.氟-18氟脱氧葡萄糖正电子发射断层扫描、镓-67闪烁扫描以及霍奇金病和非霍奇金淋巴瘤的传统分期
Am J Med. 2002 Mar;112(4):262-8. doi: 10.1016/s0002-9343(01)01117-2.
3
Negative PET: good prognosis for Hodgkin's lymphoma.PET检查结果为阴性：霍奇金淋巴瘤预后良好。
Lancet Oncol. 2015 Jun;16(6):e265. doi: 10.1016/S1470-2045(15)70210-X. Epub 2015 Apr 30.
4
The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.正电子发射断层扫描术联合[18F]2-氟-D-2-脱氧葡萄糖（FDG-PET）在霍奇金淋巴瘤和非霍奇金淋巴瘤中的应用
Hematology. 2003 Dec;8(6):403-8. doi: 10.1080/1024533032000158841.
5
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.早期中期 PET 阳性的晚期霍奇金淋巴瘤患者单独接受 BEACOPP 或联合利妥昔单抗（HD18）治疗的无进展生存期：德国霍奇金研究组开展的一项开放标签、国际、随机 3 期研究。
Lancet Oncol. 2017 Apr;18(4):454-463. doi: 10.1016/S1470-2045(17)30103-1. Epub 2017 Feb 22.
6
Hodgkin's and non-Hodgkin's lymphomas.霍奇金淋巴瘤和非霍奇金淋巴瘤。
Radiol Clin North Am. 2007 Jan;45(1):69-83. doi: 10.1016/j.rcl.2006.10.006.
7
Negative PET: no guarantee of good prognosis in Hodgkin's lymphoma.PET检查结果为阴性：不能保证霍奇金淋巴瘤预后良好。
Ann Hematol. 2015 Sep;94(9):1609-10. doi: 10.1007/s00277-015-2424-x. Epub 2015 Jun 14.
8
Positron emission tomography/computed tomography in the management of Hodgkin's disease and non-Hodgkin's lymphoma.正电子发射断层扫描/计算机断层扫描在霍奇金淋巴瘤和非霍奇金淋巴瘤治疗中的应用
Curr Probl Diagn Radiol. 2006 Jul-Aug;35(4):151-63. doi: 10.1067/j.cpradiol.2006.02.001.
9
Hodgkin's lymphoma--patient's assessment and staging.霍奇金淋巴瘤——患者评估与分期
Cancer J. 2009 Mar-Apr;15(2):138-42. doi: 10.1097/PPO.0b013e3181a27146.
10
Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.专家关于淋巴瘤正电子发射断层扫描和计算机断层扫描成像的意见。
Oncologist. 2009;14 Suppl 2:30-40. doi: 10.1634/theoncologist.2009-S2-30.

引用本文的文献

1
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma.基线IgM水平可识别预后不良的患者：一项关于经典型霍奇金淋巴瘤的单中心真实世界研究结果
Cancers (Basel). 2024 Feb 18;16(4):826. doi: 10.3390/cancers16040826.
2
Fluorodeoxyglucose-Positron Emission Tomography in Relapsed/Refractory Hodgkin Lymphoma: A Practical Approach.氟代脱氧葡萄糖正电子发射断层扫描在复发/难治性霍奇金淋巴瘤中的应用：一种实用方法。
Chemotherapy. 2024;69(1):1-10. doi: 10.1159/000533766. Epub 2023 Sep 14.
3
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report.霍奇金淋巴瘤治疗患者炎症性氟代脱氧葡萄糖摄取的误判：一例报告
Asia Ocean J Nucl Med Biol. 2023;11(2):171-174. doi: 10.22038/AOJNMB.2022.66011.1457.
4
Limited benefit of additional contrast-enhanced CT to end-of-treatment PET/CT evaluation in patients with follicular lymphoma.在滤泡性淋巴瘤患者中，治疗结束时 PET/CT 评估中额外增强 CT 的获益有限。
Sci Rep. 2021 Sep 16;11(1):18496. doi: 10.1038/s41598-021-98081-x.
5
Myocardial Metabolic Response Predicts Chemotherapy Curative Potential on Hodgkin Lymphoma: A Proof-of-Concept Study.心肌代谢反应预测霍奇金淋巴瘤化疗疗效：一项概念验证研究
Biomedicines. 2021 Aug 6;9(8):971. doi: 10.3390/biomedicines9080971.
6
FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在霍奇金淋巴瘤化疗后残留肿块管理中的应用
Cancers (Basel). 2021 Aug 5;13(16):3952. doi: 10.3390/cancers13163952.
7
[The prognostic significance of peripheral lymphocyte/monocyte ratio and PET-2 evaluation in adult Hodgkin's lymphoma].[外周血淋巴细胞/单核细胞比值及PET-2评估在成人霍奇金淋巴瘤中的预后意义]
Zhonghua Xue Ye Xue Za Zhi. 2019 May 14;40(5):372-377. doi: 10.3760/cma.j.issn.0253-2727.2019.05.005.
8
The role of FDG-PET in Hodgkin lymphoma.氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）在霍奇金淋巴瘤中的作用。
Contemp Oncol (Pozn). 2017;21(2):104-114. doi: 10.5114/wo.2017.68618. Epub 2017 Jun 30.
9
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients.诊断时的绝对单核细胞计数可改善早期氟脱氧葡萄糖正电子发射断层扫描（FDG-PET）在经典型霍奇金淋巴瘤患者中的预后作用。
Br J Haematol. 2018 Feb;180(4):600-602. doi: 10.1111/bjh.14406. Epub 2016 Oct 26.
10
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma.髓系介导的免疫抑制标志物精氨酸酶-1在经典型霍奇金淋巴瘤中的预后价值。
Oncotarget. 2016 Oct 11;7(41):67333-67346. doi: 10.18632/oncotarget.12024.

本文引用的文献

1
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.四项欧洲 PET 报告标准在霍奇金淋巴瘤多中心试验中的一致性。
Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1824-33. doi: 10.1007/s00259-010-1490-5. Epub 2010 May 27.
2
A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma.一种功能动态评分模型，旨在阐明霍奇金淋巴瘤患者诱导后中期氟-18-氟代脱氧葡萄糖正电子发射断层扫描结果的意义。
Haematologica. 2010 Jul;95(7):1198-206. doi: 10.3324/haematol.2009.016105. Epub 2010 Apr 21.
3
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.肿瘤相关巨噬细胞与经典型霍奇金淋巴瘤患者的生存情况
N Engl J Med. 2010 Mar 11;362(10):875-85. doi: 10.1056/NEJMoa0905680.
4
Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation.霍奇金淋巴瘤的中期正电子发射断层扫描：定义、解释规则和临床验证。
Leuk Lymphoma. 2009 Nov;50(11):1761-4. doi: 10.3109/10428190903308072.
5
Report on the First International Workshop on Interim-PET-Scan in Lymphoma.淋巴瘤临时正电子发射断层扫描国际研讨会报告。
Leuk Lymphoma. 2009 Aug;50(8):1257-60. doi: 10.1080/10428190903040048.
6
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.在霍奇金淋巴瘤模型中，共表达CCR4和靶向CD30的嵌合抗原受体的T淋巴细胞具有改善的归巢和抗肿瘤活性。
Blood. 2009 Jun 18;113(25):6392-402. doi: 10.1182/blood-2009-03-209650. Epub 2009 Apr 17.
7
Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review.氟-18-氟脱氧葡萄糖正电子发射断层扫描用于晚期霍奇金淋巴瘤和弥漫性大B细胞淋巴瘤的中期疗效评估：一项系统评价
J Clin Oncol. 2009 Apr 10;27(11):1906-14. doi: 10.1200/JCO.2008.16.0861. Epub 2009 Mar 9.
8
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value.氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）用于评估晚期霍奇金淋巴瘤患者化疗四个周期后的早期治疗反应，具有较高的阴性预测价值。
Ann Oncol. 2009 Jul;20(7):1270-4. doi: 10.1093/annonc/mdn768. Epub 2009 Feb 19.
9
Stromal gene signatures in large-B-cell lymphomas.大B细胞淋巴瘤中的基质基因特征
N Engl J Med. 2008 Nov 27;359(22):2313-23. doi: 10.1056/NEJMoa0802885.
10
Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma.治疗反应的早期预测：霍奇金淋巴瘤和非霍奇金淋巴瘤的临床意义
Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1413-20. doi: 10.1007/s00259-008-0787-0.